Transferable data exclusivity vouchers are not the solution to the antimicrobial drug development crisis: A commentary on the proposed EU pharma regulation

Access to pharmaceutical products worsened during the COVID-19 pandemic when key developers of active pharmaceutical ingredients and medicinal products prioritised their national markets. These challenges led to a stronger commitment by the European Union (EU) to become more autonomous in developing...

Full description

Bibliographic Details

Main Authors:	Berner-Rodoreda, Astrid, Cobelens, Frank, Vandamme, Anne-Mieke, Froeschi, Gunter, Skordis, Jolene, Elil, Renganathan *, t'Hoen, Ellen, Raviglione, Mario, Jahn, Albrecht, Barnighausen, Till
Format:	Article
Published:	BMJ Publishing Group 2024
Subjects:	RM Therapeutics. Pharmacology RS Pharmacy and materia medica
Online Access:	http://eprints.sunway.edu.my/2608/ https://doi.org/10.1136/bmjgh-2023-014605
Tags:	Add Tag No Tags, Be the first to tag this record!